Thiabendazole/Neomycin/Dexamethason
49 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
49
Total Reports
0
Deaths Reported
0.0%
Death Rate
Active Ingredients
Thiabendazole/Neomycin/Dexamethason
Administration Routes
UnknownAuricular (Otic)OphthalmicOral
Species Affected
Dog 20
Unknown 14
Human 8
Cat 7
Most Affected Breeds
Unknown 22
Domestic Shorthair 6
Terrier - West Highland White 1
Crossbred Canine/dog 1
Retriever - Labrador 1
Sheepdog - Old English 1
Shih Tzu 1
Poodle - Miniature 1
Bulldog - French 1
Dog (other) 1
Most Reported Reactions
Uncoded sign 14
Dropper, Abnormal 5
Eye irritation 5
Caps, Abnormal 4
Vials, Leaking 4
Lethargy (see also Central nervous system depression in 'Neurological') 3
Eye redness 3
Accidental exposure 3
Deafness NOS 3
External ear disorder NOS 3
Vomiting 2
Elevated liver enzymes 2
Outcome Breakdown
Outcome Unknown
25 (71.4%)
Recovered/Normal
9 (25.7%)
Recovered with Sequela
1 (2.9%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.